Research Topic · Peer-Reviewed

Coronavirus Vaccine

A coronavirus vaccine is a biological preparation designed to induce protective immunity against a coronavirus, training the immune system to recognise viral antigens, most commonly the spike protein, so that subsequent infection is prevented or attenuated. Vaccine platforms include nucleic-acid, viral-vector, prote…

Curated from this journal's research 📚 12 peer-reviewed articles cited Cited 24× across the literature 🔖 ISSN 2692-1537 🗓 Reviewed July 2026

Overview

A coronavirus vaccine is a biological preparation designed to induce protective immunity against a coronavirus, training the immune system to recognise viral antigens, most commonly the spike protein, so that subsequent infection is prevented or attenuated. Vaccine platforms include nucleic-acid, viral-vector, protein-subunit and inactivated approaches, each presenting antigen to elicit neutralising antibodies and cellular responses. In the context of SARS-CoV-2, vaccine development has confronted the dual challenge of rapid deployment and durable, broad protection, and research addresses the insights, prospects and challenges of bringing candidates from concept to use. Relevant work spans the immunological basis of protection, including neutralising antibodies and interferon and cytokine responses to the spike protein, and the safety considerations that accompany vaccination, such as rare post-vaccination reactions affecting the liver. The continual molecular evolution of the virus, documented through spike-gene sequence analysis and lineage comparison, bears directly on how well existing vaccines match circulating strains and motivates updated formulations. Vaccination interacts with other strategies, including immune modulation and measures to reduce infection risk. Understanding coronavirus vaccines therefore requires integrating immunology, virology and clinical evaluation to assess efficacy, safety and the need to adapt as the virus changes.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2020

The Novel Coronavirus 2019 (COVID-19): A Narrative Review

Rezapour BarataliCorresponding author
Department of Public Health, Faculty of Health, Assistant Professor, PhD in Health education and promotion, Urmia University of Medical Sciences, Urmia, Iran
International Journal of Coronaviruses Cited by 2 doi:10.14302/issn.2692-1537.ijcv-20-3373
2020

SARS-CoV-2 affected cells Pathogeny and Therapy

M.R PonizovskiyCorresponding author
Kiev, Ukraine, “Kiev regional p/n hospital”, /Head of “Laboratory Biochemistry and Toxicology”
International Journal of Coronaviruses doi:10.14302/issn.2692-1537.ijcv-20-3538

How this research is being cited

The 12 articles above have been cited 24 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Coronavirus Vaccine, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in International Journal of Coronaviruses (ISSN 2692-1537).

Journal editorial board
Dr. Omeed Memar · USA Dr. SUDIPTI GUPTA · United States Dr. Jose Luis Turabian · Spain

This page summarises published research for orientation; it is not medical or professional advice.